secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001213900-23-052948
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma extends license agreement with University of Maryland through Sept 2023, with option to Dec 2023
--------------------------------------------------------------------------------

- Term of Commercial Evaluation and License Agreement extended to September 30, 2023.
- Company may further extend to December 31, 2023 by paying $2,500 fee and providing notice by August 31, 2023.
- Amendment executed June 28, 2023; fee creditable against future patent expenses if master license signed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023052948/0001213900-23-052948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023052948/ea181159-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-052948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer